Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHematopoiesisHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsSurvival RateWhole-Body IrradiationInfectionLymphoma, T-CellSurvival AnalysisTime FactorsDoxorubicinPOEMS SyndromeHistocompatibilityPlatelet CountPrednisoneHistocompatibility TestingCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineRecombinant ProteinsBlood Cell CountFollow-Up StudiesLeukemiaAntineoplastic AgentsBone Marrow PurgingLymphomaCytomegalovirus InfectionsBlood CellsProspective StudiesGraft vs Leukemia EffectFatal OutcomeAntibodies, MonoclonalFeasibility StudiesMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticBlood Transfusion, AutologousLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionT-LymphocytesLeukocytes, MononuclearHistiocytosis, Non-Langerhans-CellLivedo ReticularisOpportunistic InfectionsHematologic DiseasesBone MarrowHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporinePrognosisBlood DonorsBreast NeoplasmsImmunosuppressionCell Separation